Breaking News Instant updates and real-time market news.

VZ

Verizon

$48.66

0.74 (1.54%)

, KO

Coca-Cola

$43.96

0.22 (0.50%)

20:25
04/23/18
04/23
20:25
04/23/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Verizon Communications (VZ), consensus $1.11... Coca-Cola (KO), consensus 46c... 3M Company (MMM), consensus $2.51... Lockheed Martin (LMT), consensus $3.42... United Technologies (UTX), consensus $1.51... Caterpillar (CAT), consensus $2.08... Eli Lilly (LLY), consensus $1.13... NextEra Energy (NEE), consensus $1.82... Biogen (BIIB), consensus $5.92... Sherwin-Williams (SHW), consensus $3.16... Travelers (TRV), consensus $2.75... Freeport-McMoRan (FCX), consensus 56c... PACCAR (PCAR), consensus $1.31... Corning (GLW), consensus 30c... Fifth Third (FITB), consensus 48c... Centene (CNC), consensus $1.88... Waters (WAT), consensus $1.55... Huntington Bancshares (HBAN), consensus 28c... Restaurant Brands (QSR), consensus 56c... Westinghouse Air Brake (WAB), consensus 90c... Polaris Industries (PII), consensus 88c... Harley-Davidson (HOG), consensus 88c... JetBlue (JBLU), consensus 20c... Santander Consumer (SC), consensus 41c... Graphic Packaging (GPK), consensus 17c... U.S. Silica (SLCA), consensus 47c.

VZ

Verizon

$48.66

0.74 (1.54%)

KO

Coca-Cola

$43.96

0.22 (0.50%)

MMM

3M

$216.01

-1.71 (-0.79%)

LMT

Lockheed Martin

$358.59

6.645 (1.89%)

UTX

United Technologies

$123.45

0.38 (0.31%)

CAT

Caterpillar

$153.96

0.72 (0.47%)

LLY

Eli Lilly

$80.25

1.16 (1.47%)

NEE

NextEra Energy

$161.23

0.46 (0.29%)

BIIB

Biogen

$259.30

-3.61 (-1.37%)

SHW

Sherwin-Williams

$387.51

-4.895 (-1.25%)

TRV

Travelers

$137.25

0.4 (0.29%)

FCX

Freeport McMoRan

$18.80

-0.56 (-2.89%)

PCAR

Paccar

$69.43

0.24 (0.35%)

GLW

Corning

$27.51

-0.05 (-0.18%)

FITB

Fifth Third

$31.92

0.49 (1.56%)

CNC

Centene

$110.61

-0.03 (-0.03%)

WAT

Waters

$209.48

1.23 (0.59%)

HBAN

Huntington Bancshares

$15.01

0.245 (1.66%)

QSR

Restaurant Brands

$53.50

-1.16 (-2.12%)

WAB

Wabtec

$88.07

0.53 (0.61%)

PII

Polaris Industries

$120.90

1.28 (1.07%)

HOG

Harley-Davidson

$41.00

-0.03 (-0.07%)

JBLU

JetBlue

$19.90

0.03 (0.15%)

SC

Santander Consumer

$15.71

0.03 (0.19%)

GPK

Graphic Packaging

$16.00

0.14 (0.88%)

SLCA

U.S. Silica

$27.56

-0.42 (-1.50%)

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 07

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 11

    May

  • 15

    May

  • 15

    May

  • 15

    May

  • 18

    May

  • 21

    May

  • 30

    May

  • 07

    Jun

  • 12

    Jun

  • 13

    Jun

  • 15

    Jun

  • 24

    Jul

  • 23

    Oct

  • 14

    Dec

VZ Verizon
$48.66

0.74 (1.54%)

04/23/18
04/23/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Michael Kors (KORS) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying the company is in the "middle innings" of a turnaround and is nearing an inflection point. 2. Verizon (VZ) upgraded to Overweight from Equal Weight at Barclays with analyst Amir Rozwadowski saying the company is better positioned than the current valuation implies. 3. Under Armour (UA, UAA) upgraded to Hold from Sell at Deutsche Bank with analyst Paul Trussell saying estimates for the first quarter and fiscal 2018 earnings are attainable, reflecting improved sell-through of new products and a commitment to cost reduction. 4. Hanesbrands (HBI) upgraded to Buy from Hold at Stifel with analyst Jim Duffy noting that the Champion brand is experiencing positive momentum in the lifestyle apparel space while its acquisitions in recent years have diversified the revenue mix and improved the overall portfolio's characteristics. 5. Exxon Mobil (XOM) upgraded to Market Perform from Underperform at Raymond James with analyst Pavel Molchanov saying Exxon's dividend yield has widened at a near-record level of 3.9% and there is a realistic chance the company will reinstate a share buyback in the near future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/18
LEHM
04/23/18
UPGRADE
Target $56
LEHM
Overweight
Verizon upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Amir Rozwadowski upgraded Verizon Communications to Overweight with an unchanged price target of $56. The company is better positioned than the current valuation implies, Rozwadowski tells investors in a research note. The analyst believes Verizon has "multiple levers" to support improving fundamentals that are not reflected in its "near historically low valuation levels." These include potential acquisitions, the trajectory of its margins and its ability to reignite service revenue growth. Rozwadowski expects the latter to improve in the second half of 2018.
04/23/18
MSCO
04/23/18
NO CHANGE
MSCO
DOJ eSim probe could be positive for smaller carriers, says Morgan Stanley
After the New York Times reported that the Justice Department has opened an investigation into potential collusion by AT&T (T), Verizon (VZ) and the GSMA to hinder the deployment of eSIM technology, Morgan Stanley analyst Simon Flannery said the news could be seen as a potential positive for the smaller carriers if the DoJ takes steps to make it easier for consumers to switch wireless carriers. He believes both T-Mobile (TMUS) and Sprint (S) would see an opportunity to take market share if eSIMs were introduced more broadly, Flannery tells investors.
04/12/18
OPCO
04/12/18
NO CHANGE
OPCO
T-Mobile, Sprint merger logic, still difficult to consummate, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that The Wall Street Journal reported on revived preliminary merger talks after T-Mobile (TMUS)/Sprint (S) ended previous M&A discussions five months ago. The analyst believes a merger offers long-term value for both companies through better scale and synergies, but friction will center on control, relative valuation and regulatory approval concessions, which need to be agreed upon up-front. Ultimately, Horan thinks the industry will consolidate to four large companies that will all offer a quad-play service, one possibility being T-Mobile/Sprint, AT&T (T), Verizon (VZ)/Dish (DISH) and a combination of the cable companies/wireless assets.
KO Coca-Cola
$43.96

0.22 (0.50%)

04/17/18
04/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Hold from Sell at Pivotal Research with analyst Brian Wieser saying the company "has a lot of positive elements" heading into the back half of the year, including a strong film slate, the launch of new direct to consumer over-the-top services, and efforts in support of the close of the Fox (FOXA) transaction. 2. Coca-Cola (KO) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong saying she sees an improving organic sales growth outlook, "cleaner base" post-refranchising, and better visibility on its margin and earnings targets. 3. Merck (MRK) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying the Keytruda+chemo combination showed better than expected results in lung cancer, boosting the company's immuno-oncology lead against Bristol-Myers (BMY). 4. Newell Brands (NWL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the stock's setup is good looking forward, with greater potential upside than downside risk over the next 12 months. 5. Twitter (TWTR) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Brian Nowak citing recent advertiser conversations that have continued to be incrementally positive about Twitter's ad business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/18
GSCO
04/17/18
UPGRADE
Target $46
GSCO
Neutral
Coca-Cola upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Coca-Cola (KO) to Neutral while reducing her price target for the shares to $46 from $47. The analyst coupled the upgrade with a downgrade of PepsiCo (PEP) to Sell. For Coca-Cola, the analyst sees an improving organic sales growth outlook, "cleaner base" post-refranchising, and better visibility on its margin and earnings targets. She calls the company "one of the rare" over 4% organic growth mega-cap stories in Americas Beverages.
04/17/18
GSCO
04/17/18
DOWNGRADE
Target $110
GSCO
Sell
PepsiCo downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Judy Hong downgraded PepsiCo (PEP) to Sell and lowered her price target for the shares to $110 from $118. The potential for continued softer North American Beverage volumes could weigh on the company's organic sales growth, Hong tells investors in a research note. She believes PepsiCo's organic growth underperformance relative to Coca-Cola (KO) could widen. Further, Coca-Cola's current price-to-earnings premium versus PepsiCo of 10% could widen to 15%, the analyst contends.
03/14/18
RBCM
03/14/18
NO CHANGE
Target $56
RBCM
Outperform
Coca-Cola can achieve its revenue growth target, says RBC Capital
RBC Capital analyst Nik Modi keeps his Outperform rating and $56 price target on Coca-Cola - his "top mega cap pick" - despite the poor investor sentiment on the stock driven by "rising rates, ETF outflows, and sector rotation". Modi believes that the slowdown in volume growth from 2013 was driven by specific issues around the company's bottler partners and decelerating macro environment, however the more recent data from global bottlers suggest "accelerating share gains, improving emerging market macros, improving local level execution, and more effective marketplace investment". The analyst adds that despite the stock outperforming relative to other staples, it can gain as much as 40% more over the next two years.
MMM 3M
$216.01

-1.71 (-0.79%)

03/23/18
SBSH
03/23/18
NO CHANGE
SBSH
Buy
3M guidance comments a surprise, but run not over, says Citi
Citi analyst Andrew Kaplowitz says 3M COO Mike Roman's comments yesterday that Q1 organic growth would be at the lower end of its 3%-5% organic range is a surprise. The analyst, however, does not think it marks the end of 3M's "outsized growth." He believes the guidance could be "mostly be a timing issue" given the greater than expected negative impact from Easter. The analyst keeps a Buy rating on 3M with a $284 price target in a research note titled "Guide-down a Surprise but Not the End of the Run."
04/09/18
SBSH
04/09/18
NO CHANGE
SBSH
Citi recommends Multi-Industry stocks following year-to-date weakness
Citi analyst Andrew Kaplowitz tells investors to take advantage of the year-to-date weakness in Multi-Industry stocks ahead of the Q1 earnings season. U.S. tax reform, a still strong developing market environment and a slowly improving project-based environment should be catalysts for growth, Kaplowitz writes in a research note. The analyst prefers shares of Honeywell (HON), Gardner Denver (GDI), Ingersoll-Rand (IR), Johnson Controls (JCI), 3M (MMM) and Illinois Tool Works (ITW).
02/13/18
DBAB
02/13/18
UPGRADE
Target $275
DBAB
Buy
3M upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst John Inch upgraded 3M to Buy and raised his price target for the shares to $275 from $240. The company remains in the early innings of realizing cost-saving benefits from its reorganization, Inch tells investors in a research note. He expects the company's Business Transformation synergies to "meaningfully accelerate" beyond 2018. Further, after years of U.S. pricing headwinds, 3M could be on the cusp of realizing improved pricing trends, the analyst adds.
02/15/18
LEHM
02/15/18
INITIATION
Target $235
LEHM
Underweight
3M initiated with an Underweight at Barclays
Barclays analyst Julian Mitchell started 3M with an Underweight rating and $235 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
LMT Lockheed Martin
$358.59

6.645 (1.89%)

02/06/18
ARGS
02/06/18
NO CHANGE
Target $385
ARGS
Buy
Lockheed Martin price target raised to $385 from $340 at Argus
Argus analyst John Eade raised his price target on Lockheed Martin to $385 and kept his Buy rating, with the stock outperforming relative to the broader market over the past quarter. Eade notes that a "GOP-controlled House, Senate and White House should bode well for defense spending", while the company's management has a history of "managing through challenges". The analyst adds that his new price target assumes "continued strong earnings based on increased U.S. and international defense spending".
03/29/18
LEHM
03/29/18
INITIATION
Target $369
LEHM
Equal Weight
Lockheed Martin initiated with an Equal Weight at Barclays
Barclays analyst David Strauss started Lockheed Martin (LMT) with an Equal Weight rating and $369 price target. The analyst believes expectations for U.S. Aerospace & Defense are too low and initiated the sector with a Positive rating. Fundamentals look poised to deliver accelerating growth against consensus, the analyst contends. He favors TransDigm Group (TDG) in Aerospace and his top pick overall is L3 Technologies (LLL).
03/29/18
03/29/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA), Allegheny Technologies (ATI), Textron (TXT), Spirit AeroSystems (SPR), Northrop Grumman (NOC), Bombardier (BDRBF), Huntington Ingalls (HII), L3 (LLL) and General Dynamics (GD) were initiated with an Overweight at Barclays, while Arconic (ARNC), Harris (HRS), Lockheed Martin (LMT), Triumph Group (TGI), Raytheon (RTN) and Hexcel (HXL) initiated with an Equal Weight and Esterline (ESL) and BWX Technologies (BWXT) were initiated wtih an Underweight. 2. Spotify (SPOT) initiated with an Outperform at RBC Capital. 3. International Paper (IP) initiated with a Buy at UBS. 4. American Homes 4 Rent (AMH) and Invitation Homes (INVH) initiated with an Outperform at Baird. 5. Pilgrim's Pride (PPC) initiated with a Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/02/18
BERN
03/02/18
NO CHANGE
Target $255
BERN
Outperform
Raytheon remains 'top pick' in defense sector, says Bernstein
Bernstein analyst Douglas Harned continues to view Raytheon (RTN) as his "top pick" in the defense space in light of recent Q4 results and progress on the defense budget, which is "more positive" following an agreement in Congress on budget top lines for FY18 and FY19, and publication of a President's budget request for FY19. In a research note to investors, Harned said that while yesterday's announcement of 25% tariffs on steel and 10% on aluminum is negative, most defense contracts should be protected by long-term agreements. Raytheon's business mix, with 40% of revenues coming from missile defense and tactical missiles, looks "most positive," he said, but noted that other defense names, including General Dynamics (GD), Huntington Ingalls (HII), Lockheed Martin (LMT) and Northrop Grumman (NOC), are all rated Market Perform given high valuations.
UTX United Technologies
$123.45

0.38 (0.31%)

03/15/18
UBSW
03/15/18
NO CHANGE
Target $155
UBSW
Buy
United Technologies break-up not worth disruption, says UBS
UBS analyst Steven Winoker said he does not think it is worth breaking up United Technologies at this point as it will not be worth the disruption in business and he sees only a slight increase in the sum-of-the-parts valuation. However, he still sees roughly 20% upside in the shares. Winoker reiterated his Buy rating and $155 price target on United Technologies shares.
03/19/18
UBSW
03/19/18
NO CHANGE
Target $155
UBSW
Buy
United Technologies break-up likely unless stock rallies significantly, says UBS
A break-up of United Technologies is likely unless the stock appreciates significantly, UBS analyst Steven Winoker tells investors in a research note following the company's investor day. The analyst's break-up valuation improved to $154 per share at the current midpoint, from $146 last week, following United's comments. Winoker does see advantages to United Technologies' scale as one company and has concerns "with potential disruption/ inefficiencies," but he adds: "at the end of the day, we think UTX will break-up if its value is not realized in its current form." The analyst keeps a Buy rating on the shares with a $155 price target.
02/15/18
LEHM
02/15/18
INITIATION
Target $157
LEHM
Overweight
United Technologies initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started United Technologies with an Overweight rating and $157 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/09/18
02/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Sector Perform from Underperform at RBC Capital with analyst Mark Mahaney saying the fourth quarter revenue and EBITDA were materially better than expected, and while MAU's were below consensus, DAU's grew for the first time at a double-digit rate. 2. iRobot (IRBT) upgraded to Outperform from Market Perform at Raymond James with analyst Mark Strouse saying he sees a more balanced risk/reward following the recent pullback in the shares. 3. Regeneron (REGN) upgraded to Outperform from Neutral at Baird with analyst Brian Skorney noting its selloff since last year and believes its valuation has reached a point where the selloff is overdone. 4. Teva (TEVA) upgraded to Sector Perform from Underperform at RBC Capital with analyst Randall Stanicky saying the 11% sell-off in the stock price following the company's guidance update has removed the debate around 2018 EBITDA target and sees limited downside from the current levels. 5. United Technologies (UTX) upgraded to Buy from Hold at Argus with analyst John Eade saying the company remains a leader in a number of global industries and should continue to benefit from population growth and middle class expansion in developing markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CAT Caterpillar
$153.96

0.72 (0.47%)

04/16/18
WELS
04/16/18
NO CHANGE
Target $180
WELS
Outperform
Caterpillar price target lowered to $180 from $200 at Wells Fargo
Wells Fargo analyst Andrew Casey lowered his price target for Caterpillar to $180 from $200, while reiterating an Outperform rating on the stock. The analyst notes that his U.S. power generation check was the most positive in six years.
04/23/18
SBSH
04/23/18
UPGRADE
Target $180
SBSH
Buy
Citi upgrades Caterpillar to Buy with $185 price target
Citi analyst Timothy Thein upgraded Caterpillar to Buy from Neutral while lowering his price target for the shares to $180 from $185. The shares can outperform over the next 6-12 months on positive estimate revisions, increased capital returns and improving China macro data points, Thein tells investors in a research note. He sees operating leverage remaining a key source of differentiation for Industrials and expects Caterpillar's incrementals "will put it on the winning side in 2018."
04/23/18
SBSH
04/23/18
UPGRADE
SBSH
Buy
Caterpillar upgraded to Buy from Neutral at Citi
04/11/18
04/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), Apple (AAPL), and Facebook (FB) were initiated with a Buy at Monness Crespi. 2. Caterpillar (CAT) initiated with a Buy at Buckingham. 3. JPMorgan (JPM) initiated with a Hold at HSBC. 4. eBay (EBAY) assumed with an Overweight at KeyBanc. 5. Ericsson (ERIC) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
LLY Eli Lilly
$80.25

1.16 (1.47%)

04/13/18
BMOC
04/13/18
UPGRADE
Target $79
BMOC
Market Perform
Eli Lilly upgraded to Market Perform at BMO Capital on valuation
As reported earlier, BMO Capital analyst Alex Arfaei upgraded Eli Lilly to Market Perform from Underperform and raised his price target to $79 from $74. The analyst believes that his previously expressed concerns around the downside risks for Humalog, cautious outlook for Vernezio, and uncertainty around Bari are "mostly reflected" in the stock, with more balance in risk-reward going forward. While he anticipates 2018 to be volatile as maturing diabetes franchise constrains the company's growth plans, Arfaei also sees some tailwinds for Eli Lilly around continued strong growth of Trulicity, further growth of Taltz, Jardiance, and Basglar, as well as potential divestiture of Elanco.
04/13/18
BMOC
04/13/18
UPGRADE
Target $79
BMOC
Market Perform
Eli Lilly upgraded to Market Perform from Underperform at BMO Capital
BMO Capital analyst Alex Arfaei upgraded Eli Lilly to Market Perform and raised his price target for the shares to $79 from $74.
04/13/18
04/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: Netflix (NFLX) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft saying he underestimated the market's willingness to underwrite several years of negative free cash flow to drive growth. 2. Eli Lilly (LLY) upgraded to Market Perform from Underperform at BMO Capital with analyst Alex Arfaei saying he believes that his previously expressed concerns around the downside risks for Humalog, cautious outlook for Vernezio, and uncertainty around Bari are "mostly reflected" in the stock, with more balance in risk-reward going forward. 3. Willis Towers Watson (WLTW) upgraded to Buy from Hold at Sandler O'Neill with analyst Paul Newsome saying he is making a valuation call with the stock down to "both absolute and relative valuations that we have not seen since there were significant concerns about the Willis/Towers Watson merger and the company's ability to generate organic growth." 4. Shaw Communications (SJR) upgraded to Buy from Hold at Canaccord and to Outperform from Sector Perform at Scotiabank. 5. eBay (EBAY) upgraded to Buy from Neutral at Monness Crespi with analyst Jim Chartier saying eBay's structured data initiatives have meaningfully improved the eBay marketplace experience for buyers and sellers, resulting in gross merchandise value inflecting to up 7% in the fourth quarter of 2017 from up 1% in the third quarter of 2016. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/18
RBCM
04/23/18
NO CHANGE
RBCM
Outperform
Incyte AdCom meeting going more favorably than docs suggested, says RBC Capital
RBC Capital analyst Brian Abrahams said the FDA advisory committee meeting for baricitinib, a rheumatoid arthritis treatment developed by Incyte (INCY) and submitted for review by Eli Lilly (LLY), seems "considerably less negative" than the briefing documents for the meeting had suggested. He sees the tone of the panel and the panelist Q&A suggesting a high likelihood that baricitinib will be approved, with the potential still existing that even a 4mg version could be approved in some form. Abrahams has an Outperform rating and $75 price target on Incyte shares.
NEE NextEra Energy
$161.23

0.46 (0.29%)

12/06/17
GABE
12/06/17
NO CHANGE
GABE
Buy
NextEra Energy Partners named a Best Idea for 2018 at Gabelli
Gabelli analyst Tim Winter named NextEra Energy Partners (NEP) a Best Idea in the utility sector for 2018. The analyst sees significant drop-down opportunities from sponsor and general partner NextEra Energy (NEE). The analyst rates NextEra Energy Partners with a Buy and $46 PMV.
12/07/17
FBCO
12/07/17
INITIATION
Target $173
FBCO
Outperform
NextEra Energy initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Weinstein starts NextEra Energy with an Outperform rating and $173 price target. The analyst says the company's emphasis on a continent-wide non-regulated renewable development strategy is "extraordinary" among its integrated utility peers. He views NextEra as the "premier way to invest in a coming revolution for the electric generation industry."
12/14/17
HDLY
12/14/17
NO CHANGE
HDLY
Hilliard Lyons Top Ideas for Year-End 2017
Hilliard Lyons Research named its Top Ideas for Year-End 2017. They are: Pinnacle Financial (PNFP), Disney (DIS), J.M. Smucker (SJM), NextEra Energy (NEE), Zoetis (ZTS), Leggett & Platt (LEG), South Jersey Industries (SJI), Tanger Factory (SKT), Physicians Realty Trust (DOC), VMware (VMW), AT&T (T), and American Water (AWK).
02/02/18
UBSW
02/02/18
INITIATION
Target $177
UBSW
Buy
NextEra Energy initiated with a Buy at UBS
UBS analyst Daniel Ford started NextEra Energy with a Buy rating and $177 price target.
BIIB Biogen
$259.30

-3.61 (-1.37%)

04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Buy
Jefferies ponders other potential suitors for AveXis after Novartis deal
Jefferies analyst Biren Amin asks who else can jump into the mix after AveXis (AVXS) agreed to be acquired by Novartis (NVS) for $218 per share in an all-cash deal. The analyst, who does not expect anti-trust issues to arise with the deal on the table, notes the speculation that Biogen (BIIB) may need to evaluate AveXis at some point. The Novartis deal could be the "trigger that forces it to do so," Amin writes in a research note. Further, the analyst has always felt Roche (RHHBY) could have an interest in AveXis given its development program with RG7916. He points out that AveXis Chairman Dan Welch was the CEO of Intermune when Roche purchased the company in 2014 for $8.3B. AveXis in premarket trading is up 81%, or $94.14, to $210.05.
04/23/18
SBSH
04/23/18
NO CHANGE
SBSH
Buy
Biogen collaboration expansion with Ionis a smart deal, says Citi
Citi analyst Robyn Karnauskas believes Biogen's (BIIB) collaboration expansion with Ionis Pharmaceuticals (IONS) is a smart deal. The deal gives Biogen access to a number of new drug targets, Karnauskas tells investors in a research note. Further, the analyst notes that Biogen still has the financial flexibility after this transaction to enter further partnerships or do acquisitions. She keeps a Neutral rating on shares of Biogen.
04/10/18
BERN
04/10/18
NO CHANGE
Target $318
BERN
Outperform
Acquisition of AveXis increases pressure on Biogen Spinraza, says Bernstein
Bernstein analyst Aaron Gal believes that Biogen (BIIB) odds of counter-bidding Novartis (NVS) takeout offer for AveXis (AVXS) are low, primarily because of FTC concerns. Nonetheless, the analyst notes that this increases pressure on Biogen's Spinraza as it puts the competing SMA program in the hands of a well-funded, payer-competent, global-reaching company. Gal reiterates an Outperform rating and $318 price target on Biogen's shares.
04/11/18
MZHO
04/11/18
NO CHANGE
Target $433
MZHO
Buy
Biogen could have $11-$20 upside on Samsung Bioepis report, says Mizuho
After Business Korea reported that Samsung is in talks to buy Biogen's stake, or part of it, in the companies' Samsung Bioepis joint venture, Mizuho analyst Salim Syed estimated that such a renegotiation could represent as much as $11-$20, or 4-8%, upside for Biogen shares if the article's numbers are accurate. Syed maintains a Buy rating and $433 price target on Biogen shares.
SHW Sherwin-Williams
$387.51

-4.895 (-1.25%)

02/02/18
GHSC
02/02/18
UPGRADE
Target $465
GHSC
Buy
Sherwin-Williams upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Michael Harrison upgraded Sherwin-Williams to Buy with a $465 price target, up from $430, saying the Valspar deal adds another layer of potential growth. Harrison said Sherwin is on track to see net debt-to-EBITDA fall below 3x in 2018, which should lead to increased buybacks and M&A long-term, increasing shareholder gains. Also, the analyst expects Sherwin to benefit from a strong remodeling market and pricing power.
02/02/18
02/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Buy from Hold at Argus with analyst Stephen Biggar saying the stock should trade above its historical average earnings multiple, with effective tax rate of 20% seen below 27% in 2017 as well as continued strong purchase volumes and growth in cross-border volumes and processed transactions. 2. Tableau (DATA) upgraded to Hold from Sell at Maxim with analyst Nehal Chokshi citing normalized bookings accelerating to 26% growth in the fourth quarter and sees normalized sales productivity stabilizing at about a 33% level. 3. Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale with analyst Warren Ackerman saying fourth quarter results were "solid" as emerging markets are rebounding strongly and the worst is over in North America. 4. Huntington Ingalls (HII) upgraded to Outperform from Market Perform at Cowen with analyst Gautam Khanna saying the shares are "excessively discounted" relative to the large cap defense peer average. 5. Sherwin-Williams (SHW) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying the Valspar deal adds another layer of potential growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/18
CLVD
03/07/18
NO CHANGE
CLVD
Buy
Sherwin-Williams volume, price progress can offset rising costs, says Cleveland Research
Cleveland Research analyst Eric Bosshard said his work suggests Sherwin-Williams continues to execute well, as he found signs of solid year to date growth in pro paint volume. Paint input costs are looking a bit worse for 2018 than his work 30 days ago, but price increase traction and volume gains can offset the bulk of input cost inflation through 2018. He maintains a Buy rating on Sherwin-Williams shares.
03/27/18
BMOC
03/27/18
INITIATION
Target $453
BMOC
Market Perform
Sherwin-Williams initiated with a Market Perform at BMO Capital
BMO Capital analyst John McNulty started Sherwin-Williams with a Market Perform rating and $453 price target.
TRV Travelers
$137.25

0.4 (0.29%)

01/24/18
WELS
01/24/18
NO CHANGE
Target $142
WELS
Market Perform
Travelers price target raised to $142 from $133 at Wells Fargo
Wells Fargo analyst Elyse Greenspan raised her price target for Travelers to $142 from $133 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
01/26/18
ATLE
01/26/18
UPGRADE
ATLE
Neutral
Travelers upgraded to Neutral from Underweight at Atlantic Equities
01/26/18
01/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zillow (Z, ZG) upgraded to Overweight from Sector Weight at KeyBanc with analyst Brad Erickson saying the risk/reward is "too good to pass up" with the stock down 6% since July. 2. Travelers (TRV) upgraded to Neutral from Underweight at Atlantic Equities. 3. Gilead (GILD) upgraded to Buy from Hold at Jefferies with analyst Michael Yee saying Gilead "has had it tough since 2015," but he worst is "generally moving behind them." 4. Whirlpool (WHR) upgraded to Outperform from Market Perform at Raymond James with analyst Sam Darkatsh saying that while EMEA margins were depressed and raw material inflation has expanded further, the next few quarters will be supportive on the prospects of "price hike stickiness, improved washer margins, and conservative guidance". 5. Jack in the Box (JACK) upgraded to Outperform from Neutral at Wedbush with analyst Nick Setyan saying that he expects stabilization in same-store sales growth within management's current 1%-2% guidance range given easier year-over-year comparisons starting in the second quarter. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/18
BOFA
01/09/18
UPGRADE
BOFA
Buy
Travelers upgraded to Buy from Neutral at BofA/Merrill
FCX Freeport McMoRan
$18.80

-0.56 (-2.89%)

01/21/18
CIBC
01/21/18
DOWNGRADE
CIBC
Neutral
Freeport McMoRan downgraded to Neutral from Outperformer at CIBC
CIBC downgraded Freeport McMoRan to Neutral citing recent shares strength.
01/26/18
SBSH
01/26/18
NO CHANGE
Target $20
SBSH
Neutral
Freeport believes Grasberg risk largely mitigated, says Citi
Citi analyst Alexander Hacking says Freeport McMoRan (FCX) management, in a conference call, confirmed its preference that Rio Tinto (RIO) sell its 40% Grasberg stake to the government. The tone seemed to suggest that many key issues remain to be resolved, thus a deal is not imminent, Hacking tells investors in a research note. Further, the analyst notes that Freeport management believes project risk is largely mitigated based on development to date. This is very positive, Hacking writes. Hacking adds that Freeport is aiming to resume dividend payments over the coming quarters. He raised his price target for the shares to $20 from $16 and keeps a Neutral rating Freeport. A successful resolution in Indonesia and $3.18/lb long-term copper price are fully priced into the shares, Hacking contends.
03/12/18
RBCM
03/12/18
NO CHANGE
Target $22
RBCM
Sector Perform
Freeport McMoRan price target raised to $22 from $17 at RBC Capital
RBC Capital analyst Stephen Walker raised his price target on Freeport McMoRan (FCX) to $22, modeling an improvement to the company's balance sheet and potential for capital return if the progressing negotiations toward the selldown of Grasberg assets to Rio Tinto (RIO) for $5.1B proceeds. Walker adds that the capital could also be used toward Freeport McMoRan commencing the Lone Star brown fields expansion and El Abra pre-development work. The analyst keeps his Sector Perform rating, saying his NAV and financial estimates for Freeport McMoRan have improved.
03/20/18
GSCO
03/20/18
INITIATION
Target $23
GSCO
Buy
Freeport McMoRan initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Matthew Korn started Freeport McMoRan with a Buy rating and $23 price target while rolling out coverage on the Americas Metals & Mining sector with an Attractive view. The analyst sees shares in the space supported by high commodity prices, "more rational" supply dynamics and "healthier" balance sheets.
PCAR Paccar
$69.43

0.24 (0.35%)

03/19/18
DBAB
03/19/18
DOWNGRADE
Target $62
DBAB
Sell
Paccar downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Nicole DeBlase downgraded Paccar to Sell and lowered her price target for the shares to $62 from $69. The analyst reevaluated ratings in the Machinery space following the recent pullback in the shares. She sees near- and medium term risk for Paccar with the U.S. levying widespread tariffs on steel and aluminum imports given the "substantial steel content" in heavy machinery.
03/06/18
03/06/18
UPGRADE
Target $85

Buy
Following strong dealer checks, Longbow upgrades Paccar to Buy
As previously reported, Longbow analyst Faheem Sabeiha upgraded Paccar to Buy from Neutral after his dealer contacts offered a higher sales outlook and FTR Associates issued a higher production forecast for 2018 and 2019. He additionally estimates higher material costs will only have a 15c-20c per share impact even before factoring the offsets from cost-sharing and potentially higher list pricing, Sabeiha tells investors. The analyst, who sees the recent pull-back in Paccar as a great entry point for a "best-in-class" operator, set an $85 price target on the stock.
04/03/18
JPMS
04/03/18
NO CHANGE
JPMS
North American Class 8 truck orders up 102% in March, says JPMorgan
JPMorgan analyst Ann Duignan noted that ACT Research released preliminary North American truck order data for March that showed Class 8 net orders of 46,900 units, up 102% year-over-year. Navistar (NAV), Paccar (PCAR), Cummins (CMI), Eaton (ETN) and Allison Transmission (ALSN) have been cited previously as stocks impacted by truck orders.
04/04/18
JPMS
04/04/18
NO CHANGE
JPMS
March Class 8 truck orders rose 102% versus last year, says JPMorgan
According to ACT Research, March Class 8 tuck orders were 46,900 units, up 102% year-over-over and 16% month-over-month, JPMorgan analyst Ann Duignan tells investors in a research note. Class 5-7 March net orders were 27,400 units, up 10% year-over-year and up 3% month-over-month, the analyst adds. She believes U.S. macro indicators for truck purchases have continued to trend positively. Truck orders have the largest incremental impact on Navistar (NAV), Paccar (PCAR), Cummins (CMI), Eaton (ETN), and Allison Transmission (ALSN), Duignan points out.
GLW Corning
$27.51

-0.05 (-0.18%)

04/26/17
UBSW
04/26/17
NO CHANGE
Target $29
UBSW
Neutral
Corning doing better than expected, says UBS
UBS analyst Tejas Venkatesh noted Corning (GLW) beat expectations for Q1 and its guidance surpassed expectations, leading him to say the company is doing better than expected. He also believes the company's deal with Verizon (VZ) is significant, though he maintains his Neutral rating on Corning shares due to currency risk that keeps him on the sidelines. Venkatesh raised his price target to $28.50 from $26 on Corning.
08/15/17
GSCO
08/15/17
DOWNGRADE
Target $26
GSCO
Sell
Corning downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Doug Clark downgraded Corning to Sell (GLW) and cut his price target for the shares to $26 from $29. The analyst believes the LCD cycle "may be approaching a downturn." Supply chain inventory levels have been ticking higher, panel prices have begun to decline and TV makers are reducing production targets, Clark tells investors in a research note. He sees risk to estimates and Corning's valuation. Clark this morning also upgraded GoPro (GPRO) to Neutral.
FITB Fifth Third
$31.92

0.49 (1.56%)

11/17/17
MACQ
11/17/17
DOWNGRADE
Target $26
MACQ
Underperform
Fifth Third downgraded to Underperform from Neutral at Macquarie
Macquarie analyst David Konrad downgraded Fifth Third to Underperform with a $26 price target due to below peer returns, lowered PTPP expectations, and valuation.
11/15/17
MSCO
11/15/17
NO CHANGE
MSCO
Morgan Stanley says higher SIFI threshold could benefit Comerica, CIT, Zions
After Senate Banking Committee Chairman Mike Crapo proposed a bill in the Senate that would effectively remove the SIFI threshold for banks under $250B, Morgan Stanley analyst Ken Zerbe estimated that banks with $50B-$100B in assets could see a 12% increase in 2020 EPS and a 15% bump in 2021. He sees the largest potential increase at Comerica (CMA), followed by CIT Group (CIT) and Zions Bancorp (ZION). Zerbe projects the least EPS benefit for SunTrust (STI), Regions Financial (RF), Ally Financial (ALLY) and Discover (DFS), he tells investors. Other banks he lists in his note as potentially impacted by SIFI and CCAR changes include Synchrony (SYF), M&T Bank (MTB), KeyCorp (KEY), Fifth Third (FITB), BB&T (BBT), Citizens Financial (CFG) and Huntington Bancshares (HBAN).
02/14/18
OPCO
02/14/18
NO CHANGE
OPCO
Oppenheimer dropping coverage of Fifth Third
Oppenheimer is discontinuing equity research coverage of Fifth Third due to a realignment in analyst coverage.
10/02/17
BARD
10/02/17
DOWNGRADE
Target $24
BARD
Underperform
Fifth Third downgraded to Underperform from Neutral at Baird
Baird analyst David George downgraded Fifth Third to Underperform from Neutral as it has outperformed most banks in Q3 and now trades at a premium to peers. He thinks it will be difficult to reach Project North Star targets without macro help and that significant execution risk remains. George maintained his $24 price target on Fifth Third.
CNC Centene
$110.61

-0.03 (-0.03%)

04/11/18
WELS
04/11/18
NO CHANGE
WELS
Centene contract win in Pennsylvania looks set to be rebid, says Wells Fargo
Wells Fargo analyst Peter Costa said he believes the Pennsylvania Commonwealth Court ruled on the side of UnitedHealth (UNH) that the state Department of Human Services violated the state's procurement code when it had previously awarded a Medicaid contract to Centene (CNC). Given this ruling, Costa thinks the state will have to start the procurement process for the third time. He views the court ruling as a modest positive for UnitedHealth and Aetna (AET) and a modest negative for Centene (CNC), though he also noted that this win was not in Centene's 2018 guidance. Costa has Outperform ratings on all three stocks mentioned.
03/26/18
BMOC
03/26/18
NO CHANGE
BMOC
Outperform
Centene weakness on NY worries a buying opportunity, says BMO Capital
BMO Capital analyst Matthew Borsch said he would not overreact to a Politico report that Centene's pending acquisition of Fidelis health plan is in jeopardy due to a fight between the Archdiocese of New York and Governor Cuomo. The dispute may impact the deal timing, but both parties have more to gain than lose and he suspects the deal is still substantially more likely than not to get done, Borsch tells investors. The analyst, who said he would be a buyer on any weakness, keeps an Outperform rating on Centene, which he identifies as his favorite name in Managed Care.
02/21/18
PIPR
02/21/18
NO CHANGE
PIPR
Piper sees 'ideal time' to buy Medicaid Managed Care Organizations
Now is an "ideal time" to step in and buy Medicaid Managed Care Organizations Centene (CNC), Molina Healthcare (MOH) and WellCare (WCG), Piper Jaffray analyst Sarah James tells investors in a research note. The stocks are down 12% over the last few weeks due to a combination of the flu and various reform/waiver concerns, the analyst points out. She does not view these as material and says "this is when you double down." Centene is James' top pick.
02/13/18
LEER
02/13/18
NO CHANGE
Target $100
LEER
Market Perform
Centene price target raised to $100 from $90 at Leerink
Leerink analyst Ana Gupte raised her price target for Centene to $100 form $90 saying the Q4 report was "good" and 2018 guidance raise for tax tailwinds was above expectations. The analyst reiterates a Market Perform rating on the shares.
WAT Waters
$209.48

1.23 (0.59%)

01/05/18
BTIG
01/05/18
INITIATION
Target $230
BTIG
Buy
Waters initiated with a Buy at BTIG
BTIG analyst Sung Ji Nam started Waters with a Buy rating and $230 price target. The analyst thinks the company is well positioned for continued solid growth in 2018.
01/03/18
EVER
01/03/18
INITIATION
Target $198
EVER
In Line
Waters initiated with an In Line at Evercore ISI
Evercore ISI analyst Ross Muken initiated Waters with an In Line and $198 price target.
12/04/17
12/04/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra saying the current valuation overly discounts the company's heightened investment cycle given its e-commerce growth opportunities. 2. Waters (WAT) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Steve Beuchaw citing the firm's October lab survey indicated that Pharma R&D budgets will accelerate in 2018 and Waters' implied market share loss in Pharma labs has moderated. 3. Globus Medical (GMED) upgraded to Outperform from Market Perform at Wells Fargo with analyst Larry Biegelsen saying he likes the company's diversification strategy amid a "weak" spine market. 4. eBay (EBAY) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying the current consensus for Gross Merchandise Volume are conservative, as it will likely accelerate its growth rate in 2018. 5. Owens Corning (OC) upgraded to Top Pick from Outperform at RBC Capital with analyst Robert Wetenhall saying the rating change reflects his increased confidence in fiscal 2018 outlook, projecting a double-digit EBITDA growth rate and a robust free cash flow generation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/04/17
12/04/17
UPGRADE
Target $230

Equal Weight
Waters upgraded to Equal Weight at Morgan Stanley as share losses moderate
As previously reported, Morgan Stanley analyst Steve Beuchaw upgraded Waters to Equal Weight from Underweight after the firm's October lab survey indicated that Pharma R&D budgets will accelerate in 2018 and Waters' implied market share loss in Pharma labs has moderated. He also has updated his tax analysis to reflect the proposed elements of the House and Senate tax bills, noting that over 95% of the company's cash is held overseas and its "repatriation opportunity can no longer be overlooked." Beuchaw raised his price target on Waters shares to $230 from $207.
HBAN Huntington Bancshares
$15.01

0.245 (1.66%)

03/21/18
UBSW
03/21/18
INITIATION
UBSW
Buy
Huntington Bancshares initiated with a Buy at UBS
01/24/18
01/24/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI with analyst Duane Pfennigwerth citing the company's investor update. 2. Huntington Bancshares (HBAN) was downgraded to Neutral from Buy at Hilliard Lyons and to Neutral from Outperform at Macquarie. 3. Range Resources (RRC) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Evan Calio saying he expects oil markets to tighten and gas to remain weak in 2018. 4. CEVA downgraded to Perform from Outperform at Oppenheimer with analyst Andrew Uerkwitz downgraded Ceva (CEVA) to Perform from Outperform saying the valuation looks "full" at current levels. 5. Aaron's (AAN) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation rather than fundamentals, forecasting the company's core business to improve sequentially and also see benefits from the U.S. tax changes. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/18
HDLY
02/09/18
UPGRADE
Target $17
HDLY
Buy
Huntington Bancshares upgraded to Buy from Neutral at Hilliard Lyons
Hilliard Lyons analyst Andrew Stapp upgraded Huntington Bancshares to Buy from Neutral, stating he does not understand why the stock and the wider banking sector have been negatively impacted by the recent pullback in equity valuations. While higher interest rates will constrain profitability for most sectors, they should benefit banks such as Huntington, concluded Stapp, who keeps a $17 price target on the shares.
03/22/18
UBSW
03/22/18
INITIATION
Target $20
UBSW
Buy
Huntington Bancshares initiated with a Buy at UBS
UBS analyst Brock Vandervliet started Huntington Bancshares with a Buy rating and $20 price target. The analyst rolled out coverage last night on the Mid-Cap Banks. He sees performance differentiation "playing out more starkly" than investors may expect with "increasingly advantaged and disadvantaged participants."
QSR Restaurant Brands
$53.50

-1.16 (-2.12%)

04/23/18
BMOC
04/23/18
DOWNGRADE
Target $58
BMOC
Market Perform
Restaurant Brands cut to Market Perform at BMO Capital on bad Tim Horton's press
As reported earlier, BMO Capital analyst Peter Sklar downgraded Restaurant Brands to Market Perform from Outperform and lowered his price target to $58 from $70. The analyst cites ongoing "bad press" around Tim Hortons, which has seen a rise of infighting between franchisees amid the cost-reduction efforts by Restaurant Brands/3G Capital. Sklar is warning that the tension could result in lower SSS results over the comping quarters from declining brand perception suggested by his customer survey of over 700 Canadian customers, 28% of whom said their view of Tim Hortons has become more negative over the past year.
03/26/18
03/26/18
UPGRADE
Target $71

Overweight
Restaurant Brands upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley analyst John Glass upgraded Restaurant Brands (QSR) to Overweight from Equal Weight as he sees the stock as being the most mispriced, based on free cash flow yield, among a peer group of "largely franchised" restaurants. He raised his price target on the owner of Burger King and Tim Hortons to $71 from $69. Glass also downgraded Jack in the Box (JACK) to Equal Weight from Overweight this morning.
04/19/18
RBCM
04/19/18
NO CHANGE
Target $72
RBCM
Outperform
Restaurant Brands price target lowered to $72 from $78 at RBC Capital
RBC Capital analyst David Palmer lowered his price target on Restaurant Brands to $72, citing "sluggish" Tim Horton's Canada sales which he says impacts investor sentiment more than earnings. The analyst keeps his Outperform rating on Restaurant Brands however, noting that it represents the "greatest potential upside story in 2018" longer term which will depend on the execution at Tim Horton's, unit growth acceleration at Popeye's, and the launch of a more impactful digital strategy.
04/23/18
BMOC
04/23/18
DOWNGRADE
BMOC
Market Perform
Restaurant Brands downgraded to Market Perform from Outperform at BMO Capital
WAB Wabtec
$88.07

0.53 (0.61%)

04/23/18
04/23/18
UPGRADE
Target $99

Buy
Wabtec upgraded to Buy on potential for transfomative GE deal at Stifel
As previously reported, Stifel analyst Michael Baudendistel upgraded Wabtec (WAB) to Buy from Hold after Bloomberg reported that the company was in discussions to acquire GE Transportation from General Electric (GE). While he said he does "not profess to know which strategic alternative for GE Transportation will come to fruition," he believes there is strategic rationale for a deal with Wabtec and that possibility improves his view on the stock's risk/reward balance, Baudendistel tells investors. Wabtec would be buying GE's business at a cyclical low point, and he believes they understand that better than most other potential acquirers, added the analyst, who raised his price target on Wabtec shares to $99 from $75, noting that this revised target includes a premium for the possible acquisition.
04/23/18
SPHN
04/23/18
NO CHANGE
Target $89
SPHN
Overweight
GE Transportation deal could be significant catalyst for Wabtec, says Stephens
Stephens analyst Justin Long said it's hard to peg the probability that Wabtec (WAB) acquires GE's (GE) Transportation unit, as Bloomberg reported that the two are discussing, but given Bloomberg being a reliable source and the potential for meaningful strategic and financial benefits from such a deal, his "best guess" would put the probability over 50%, he tells investors. He maintains an Overweight rating on Wabtec, adding that his estimates and $89 price target are under review given the deal potential.
02/16/18
02/16/18
UPGRADE

Outperform
Wabtec upgraded to Outperform at Wolfe Research
As previously reported, Wolfe Research upgraded Wabtec to Outperform from Peer Perform with an $88 price target. Analyst Logan Purk maintained his quarterly estimates ahead of Wabtec's report next week saying there are signs of a bottom in freight sales and shares have underperform the Transport index by 55% since 2016. Purk said same-store revenue inflected positively in Q4 for the first time in 10 quarters and expects revenues to start growing in C18.
04/23/18
STFL
04/23/18
UPGRADE
STFL
Buy
Wabtec upgraded to Buy from Hold at Stifel
PII Polaris Industries
$120.90

1.28 (1.07%)

04/09/18
BMOC
04/09/18
NO CHANGE
Target $125
BMOC
Market Perform
Polaris Industries price target raised to $125 from $105 at BMO Capital
BMO Capital analyst Gerrick Johnson raised his price target on Polaris Industries to $125, citing "incrementally positive takeaways" from the BMO Powersports Business Dealer survey as well as his recent round of channel checks. Johnson notes that the Business Dealer survey revealed 59% of respondents reporting improving side-by-side category performance in the quarter, while the channel checks also saw sales pace recovering after a "sluggish" January. The analyst keeps his Market Perform rating on Polaris Industries, adding that while the off-road vehicle market is improving, it may take longer than expected to reach FY14/15 margin levels than expected.
02/06/18
02/06/18
UPGRADE
Target $120

Outperform
Polaris Industries upgraded to Outperform at Wells Fargo
As previously reported, Wells Fargo analyst Timothy Conder upgraded Polaris Industries to Outperform from Market Perform, with a $120 price target, saying that while he has been price-sensitive on the shares given his near-term concerns, he now believes the recent market related pullback provides an improved risk/reward entry point opportunity. Nonetheless, the analyst notes that his near-term concerns remain, namely slowing Rec/Sport side-by-side trends with growing competition from BRP and likely pending Honda entry, and resultant potential higher risk for an elevated promotional environment.
02/06/18
WELS
02/06/18
UPGRADE
WELS
Outperform
Polaris Industries upgraded to Outperform from Market Perform at Wells Fargo
01/31/18
BMOC
01/31/18
NO CHANGE
Target $105
BMOC
Market Perform
Polaris Industries price target lowered to $105 from $132 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Polaris Industries to $105 and kept his Market Perform rating after the company's Q4 earnings, citing disappointing retail performance and weaker than expected FY18 outlook. The analyst notes the 1% decline in North America retail sales despite the ORV industry growth in low-single digits, suggesting that Polaris Industries is struggling with market share declines to more aggressive competitors. He also adds that while the midpoint of FY18 guidance was above consensus, it includes the positive impact of lower expected tax rates.
HOG Harley-Davidson
$41.00

-0.03 (-0.07%)

04/16/18
WBLR
04/16/18
NO CHANGE
WBLR
Market Perform
Harley-Davidson retail sales in Q1 'remained soft,' says William Blair
William Blair analyst Sharon Zackfia expects Harley-Davidson will meet her Q1 earnings per share estimate of 95c, below the consensus estimate of $1.00, when reporting on April 24. She believes the company's domestic retail sales trends in the "seasonally small" Q1 "remained soft, particularly given frigid weather in March across much of the country." The analyst projects an approximate 7% retail sales decline domestically and a low-single-digit decline overseas, yielding a worldwide retail sales decline of roughly 5%. The analyst sees limited downside with the shares off 17% year-to-date, but maintains a Market
04/13/18
STFL
04/13/18
NO CHANGE
Target $45
STFL
Hold
Harley-Davidson price target lowered to $45 ahead of earnings at Stifel
Stifel analyst Drew Crum offered his preview of Harley-Davidson's Q1 report, due on April 24, predicting that the company will report motorcycle shipments down 12% from the prior year to 62.2K units. He expects management will provide guidance on Q2, but does not anticipate material changes to its 2018 outlook, Crum tells investors. He keeps a Hold rating on Harley shares and lowered his price target on the stock to $45 from $49.
04/11/18
WEDB
04/11/18
NO CHANGE
Target $44
WEDB
Neutral
Harley-Davidson price target lowered to $44 from $49 at Wedbush
Wedbush analyst James Hardiman lowered his price target for Harley-Davidson to $44 from $49, while reiterating a Neutral rating on the shares. Given a company that is coming off of its third straight year of declining sales and profitability, with the strong potential for a fourth, and now faces unanswered concerns regarding U.S. trade policy, the current discounted valuation for the shares is appropriate, the analyst contended.
04/17/18
GSCO
04/17/18
NO CHANGE
Target $45
GSCO
Neutral
Harley-Davidson price target lowered to $45 at Goldman Sachs on dealer checks
Goldman Sachs analyst David Tamberrino lowered his price target on Harley-Davidson to $45 from $47 while keeping his Neutral rating on the stock, saying his final set of dealer checks for Q1 suggests continued softness in sales. The analyst adds that about 50% of dealers reported annual sales declines, which up from the initially estimated 33%. While Tamberrino lowers his Q1 U.S. retail sales forecast from -7% to -8% annualized decline, he adds that the pent-up demand from adverse weather-induced underperformance will be more evident in Q2, raising his sales forecast to -2.5% decline from his prior -3.0% view.
JBLU JetBlue
$19.90

0.03 (0.15%)

03/09/18
JPMS
03/09/18
NO CHANGE
JPMS
JPMorgan sees Airlines raising Q1 outlooks at next week's conference
JPMorgan analyst James Baker believes several Airlines will raise their Q1 guidance at his firm's Aviation, Transportation and Industrials Conference next week. He expects near-term consensus estimates to move higher for the airlines coming out of the presentations, particularly for United Continental (UAL). The analyst recommends increasing exposure to the sector ahead of the conference. He raised his estimates for United the most, taking his Q1 earnings per share forecast up to 32c from 3c. Other names in the space include American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU) and Southwest (LUV).
04/12/18
IMPC
04/12/18
NO CHANGE
Target $31
IMPC
Outperform
JetBlue valuation attractive at current share levels, says Imperial Capital
Imperial Capital analyst Michael Derchin calls JetBlue Airways' valuation attractive at current share levels following the company's March traffic report. The company indicated Q1 unit revenues are expected to increase 6.1% versus initial guidance of 2.5%-5.5%, Derchin tells investors in a research note. He believes JetBlue s likely to have strong earnings growth through fiscal 2019 despite a potential pilot's contract. The analyst keeps an Outperform rating on the shares with a $31 price target.
01/30/18
01/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Strong Buy from Buy at Needham by analyst Kevin Caliendo, who contended that the stock remains underowned and, unlike its peers, yet to rally beyond the expectations of benefits from the tax changes. The analyst says the company's multiple has remained constant despite the expansion in the rest of the pharma services industry, forecasting EPS growth of 8%-10% beyond the modeled $8 per share in 2019. 2. JetBlue (JBLU) upgraded to Overweight from Neutral at JPMorgan by analyst Jamie Bakier who said the company's costs are "gradually coming under control" and its balance sheet is "sound." The analyst also upgraded United Continental (UAL) to Overweight from Underweight, saying the shares are the "cheapest in the sector and among the most washed out, having declined the most from recent highs." 3. Gilead (GILD) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who said that tax reform could lower the company's tax rate to 22% in 2018 versus prior estimates of 28%. The analyst also raised her nonalcoholic steatohepatitis and JAK-1 probability of success estimates to 50% with both Phase 3 trials expected in the next 12 months. Further, Karnauskas expects Gilead's hepatitis C virus business to stabilize by mid-2018. 4. Intel (INTC) upgraded to Buy from Neutral at Citi by analyst Christopher Danely, who said overly conservative guidance and poor sentiment from years of underperformance should drive estimates and the stock higher in the near term. He believes management's "new habit" of conservative guidance is good for the stock. 5. Albemarle (ALB) upgraded to Buy from Neutral at UBS by analyst John Roberts, who said the stock is down 23% from the November high despite no change to the outlook for lithium. The analyst attributes the pullback to larger scale lithium expansion announcements and raising concerns of potential oversupply. He believes the market is pricing in 10% annual realized price declines for Albemarle over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/18
WOLF
02/12/18
UPGRADE
WOLF
Peer Perform
JetBlue upgraded to Peer Perform from Underperform at Wolfe Research
SC Santander Consumer
$15.71

0.03 (0.19%)

02/26/18
GSCO
02/26/18
DOWNGRADE
Target $19
GSCO
Neutral
Santander Consumer downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Ryan Nash downgraded Santander Consumer USA Holdings to Neutral and lowered his price target for the shares to $19 from $22.
02/01/18
BMOC
02/01/18
NO CHANGE
Target $295
BMOC
Market Perform
Credit Acceptance price target lowered to $295 from $312 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Credit Acceptance (CACC) to $295 after the company's Q4 earnings miss, citing lower cash flow valuation and higher operating expenses. The analyst keeps his Market Perform rating, adding that Credit Acceptance stock trades at 56% premium to Santander Consumer (SC) and prefers that investors "switch" into the latter.
03/27/18
UBSW
03/27/18
INITIATION
UBSW
Neutral
Santander Consumer initiated with a Neutral at UBS
UBS analyst Eric Wasserstrom initiated Santander Consumer with a Neutral rating and $17 price target, as the analyst sees limited EPS upside for the company over the medium term.
02/01/18
PIPR
02/01/18
NO CHANGE
Target $25
PIPR
Overweight
Santander Consumer selloff brings buying opportunity, says Piper Jaffray
Piper Jaffray analyst Kevin Barker views yesterday's post-earnings selloff in shares of Santander Consumer USA Holdings as an attractive buying opportunity. Adverse credit trends are likely transitory with better metrics coming in the second half of 2018, Barker tells investors in a research note. He views the shares as attractively valued at current levels. The analyst lowered his price target for Santander Consumer to $25 from $26 and keeps an Overweight rating on the name.
GPK Graphic Packaging
$16.00

0.14 (0.88%)

08/21/17
DADA
08/21/17
NO CHANGE
DADA
Graphic Packaging shares still undervalued, says DA Davidson
DA Davidson analyst Steven Chercover says that Graphic Packaging and its fellow CRB producers have not been able to push through a second price hike as he had anticipated. However, the analyst continues to believe that the stock is undervalued and he thinks that its "record profitability, free cash flow, and the company's ability to demonstrate that pass-through pricing models can offset inflation" could enable the stock to rise further. He cut his price target on the shares to $16.50 from $17.50 but keeps a Buy rating.
10/24/17
SPHN
10/24/17
INITIATION
Target $17
SPHN
Overweight
Graphic Packaging initiated with an Overweight at Stephens
Stephens analyst Mark Connelly started Graphic Packaging with an Overweight rating and $17 price target, saying he expect earnings growth to be driven by volume and integration benefits as the company expands in the U.S. and overseas.
01/29/18
SBSH
01/29/18
NO CHANGE
SBSH
Buy
Citi moves Berry to top pick in Paper & Packaging
Citi analyst Anthony Pettinari believes Paper & Packaging stocks have further room to run following International Paper's (IP) $50 per ton containerboard price hike, which has been followed by KapStone (KS). The analyst expects other major producers to announce hikes over the next few days. His analysis suggests that even in cases where hikes were anticipated, Paper & Packaging stocks tend to outperform in the months following the price hikes as investors gain confidence in the box portion of the price hike, which can take up to nine months to fully implement. Pettinari moved Berry Global (BERY) to his top pick in the sector citing the stock's relative underperformance year-to-date.
10/24/17
SPHN
10/24/17
NO CHANGE
Target $20
SPHN
Overweight
Graphic Packaging target raised to $20 on International Paper deal at Stephens
Stephens analyst Mark Connelly, who just initiated Graphic Packaging (GPK) with an Overweight rating last night, raised his price target to $20 from $17 to reflect the benefits he sees in the company's newly announced deal to take control of International Paper's (IP) consumer packaging business. The agreement is "transformational," as it increases revenue by about 50% and opens up a range of markets, and he views Graphic's $75M synergy target as conservative, Connelly tells investors.
SLCA U.S. Silica
$27.56

-0.42 (-1.50%)

04/12/18
SPHN
04/12/18
INITIATION
Target $30
SPHN
Equal Weight
U.S. Silica initiated with an Equal Weight at Stephens
Stephens analyst Tommy Moll started U.S. Silica with an Equal Weight rating and $30 price target, stating that he believes the stock will be range-bound as investors digest its debt financed, "premium-multiple" EP Minerals acquisition. He also fears that rapid supply increases will likely pressure frac sand pricing.
02/23/18
MSCO
02/23/18
NO CHANGE
Target $47
MSCO
Overweight
U.S. Silica selloff after earnings overdone, says Morgan Stanley
Morgan Stanley analyst Connor Lynagh said he sees the post-earnings pullback in U.S. Silica as overdone. While he acknowledges concerns around increasing capital intensity and pricing pressure for Sandbox, flattish realized pricing on raw sand in Q1 and some delays in fully ramping expansion projects, he thinks the biggest change is a positive one, as U.S. Silica seems to have protected its downside as the company noted it is 70-80% contracted for 2019. Lynagh, who raised his longer-term estimates due to better visibility on the fixed pricing in the company's contract mix, lowered his price target on the stock to $47 from $52 but keeps an Overweight rating on the shares.
04/11/18
GSCO
04/11/18
DOWNGRADE
GSCO
Neutral
U.S. Silica downgraded to Neutral from Buy at Goldman Sachs
04/11/18
04/11/18
DOWNGRADE
Target $31.5

Neutral
U.S. Silica downgraded to Neutral on frac sand price concerns at Goldman Sachs
As previously reported, Goldman Sachs analyst Waqar Syed downgraded U.S. Silica (SLCA) to Neutral from Buy after he lowered his target multiple to reflect near-term peaking of frac sand margins and the prospects for frac sand price pressures beginning in the second half of this year. Syed lowered his price target on U.S. Silica to $31.50 from $37. He also lowered his price targets on frac sand peers Fairmount Santrol (FMSA), Emerge Energy (EMES) and Smart Sand (SND) to $3.75, $9 and $7.50, respectively.

TODAY'S FREE FLY STORIES

HCLP

Hi-Crush Partners

$13.20

-0.825 (-5.88%)

17:54
05/25/18
05/25
17:54
05/25/18
17:54
Hot Stocks
Hi-Crush Partners provides update on bulldozer incident in Whitehall facility »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$77.98

1.49 (1.95%)

17:37
05/25/18
05/25
17:37
05/25/18
17:37
Hot Stocks
Post Holdings reports fire in Michael Foods' plant in Pennsylvania »

Post Holdings reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:34
05/25/18
05/25
17:34
05/25/18
17:34
Hot Stocks
Abiomed to enter S&P 500 index on May 31 »

S&P MidCap 400…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

PRAH

PRA Health

$81.19

0.33 (0.41%)

GME

GameStop

$12.64

-0.1 (-0.78%)

FRED

Fred's

$1.69

0.05 (3.05%)

PRSP

Symbol now PB

$0.00

(0.00%)

RRTS

Roadrunner

$2.19

0.04 (1.86%)

DXC

DXC Technology

$94.20

-5.42 (-5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 12

    Jun

PRAH

PRA Health

$81.19

0.33 (0.41%)

, ABMD

Abiomed

$394.49

0.04 (0.01%)

17:24
05/25/18
05/25
17:24
05/25/18
17:24
Hot Stocks
Breaking Hot Stocks news story on PRA Health, Abiomed »

PRA Health to replace…

PRAH

PRA Health

$81.19

0.33 (0.41%)

ABMD

Abiomed

$394.49

0.04 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

WYN

Wyndham

$107.98

-0.58 (-0.53%)

, MSCC

Microsemi

$68.74

0.005 (0.01%)

17:23
05/25/18
05/25
17:23
05/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Wyndham, Microsemi »

Wyndham to replace…

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:21
05/25/18
05/25
17:21
05/25/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Abiomed, Wyndham »

ABIOMED to replace…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

PCG

PG&E

$44.67

0.84 (1.92%)

17:16
05/25/18
05/25
17:16
05/25/18
17:16
Periodicals
CA Forestry Dept rules PG&E equipment responsible for wildfires, Bloomberg says »

Report filed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$28.50

0.15 (0.53%)

17:09
05/25/18
05/25
17:09
05/25/18
17:09
Hot Stocks
Levin Capital Strategies reports 8.4% stake in Farmer Bros »

Levin Capital purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:07
05/25/18
05/25
17:07
05/25/18
17:07
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.22

-0.125 (-9.29%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Hot Stocks
Windstream completes one-for-five reverse stock split »

Windstream completed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPD

Enterprise Products

$27.87

-0.12 (-0.43%)

17:01
05/25/18
05/25
17:01
05/25/18
17:01
Hot Stocks
Enterprise Products conduts open season for West Texas Crude oil expansion »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$4.89

0.06 (1.24%)

16:37
05/25/18
05/25
16:37
05/25/18
16:37
Syndicate
Breaking Syndicate news story on Inovio »

Inovio files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$10.14

0.13 (1.30%)

16:36
05/25/18
05/25
16:36
05/25/18
16:36
Hot Stocks
Rent-A-Center 16.8% shareholder Engaged Capital nominates Carol McFate to Board »

On May 25, 2018, Engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$0.59

0.0086 (1.48%)

16:34
05/25/18
05/25
16:34
05/25/18
16:34
Hot Stocks
Akers Biosciences receives delinquency notice from NASDAQ »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$6.60

0.37 (5.94%)

16:31
05/25/18
05/25
16:31
05/25/18
16:31
Hot Stocks
Ditech discloses receipt of late filing notice from NYSE »

Ditech Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$28.15

-4.82 (-14.62%)

, FL

Foot Locker

$55.97

9.585 (20.67%)

16:30
05/25/18
05/25
16:30
05/25/18
16:30
General news
On The Fly: Top stock stories for Friday »

Stocks on Wall Street…

GPS

Gap

$28.15

-4.82 (-14.62%)

FL

Foot Locker

$55.97

9.585 (20.67%)

HLF

Herbalife Nutrition

$48.76

-5.09 (-9.45%)

IEP

Icahn Enterprises

$69.41

0.22 (0.32%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

DGX

Quest Diagnostics

$105.89

5 (4.96%)

UNH

UnitedHealth

$244.96

2.23 (0.92%)

ROST

Ross Stores

$77.35

-5.6 (-6.75%)

ADSK

Autodesk

$132.80

-5.96 (-4.30%)

AAL

American Airlines

$44.89

1.34 (3.08%)

LUV

Southwest

$52.86

1.65 (3.22%)

DAL

Delta Air Lines

$55.89

1.48 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 29

    Jun

16:30
05/25/18
05/25
16:30
05/25/18
16:30
Options
Preliminary option volume of 16.4M today »

Preliminary option volume…

VTL

Vital Therapies

$5.65

-0.475 (-7.76%)

16:26
05/25/18
05/25
16:26
05/25/18
16:26
Syndicate
Breaking Syndicate news story on Vital Therapies »

Vital Therapies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

VTL

Vital Therapies

$5.65

-0.475 (-7.76%)

16:26
05/25/18
05/25
16:26
05/25/18
16:26
Syndicate
Breaking Syndicate news story on Vital Therapies »

Vital Therapies files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

LNC

Lincoln National

$68.89

-0.555 (-0.80%)

16:24
05/25/18
05/25
16:24
05/25/18
16:24
Syndicate
Breaking Syndicate news story on Lincoln National »

Lincoln National files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGLY

Digital Ally

$2.63

0.075 (2.94%)

16:23
05/25/18
05/25
16:23
05/25/18
16:23
Syndicate
Breaking Syndicate news story on Digital Ally »

Digital Ally files $25M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNGX

Soligenix

$1.58

-0.005 (-0.32%)

16:23
05/25/18
05/25
16:23
05/25/18
16:23
Syndicate
Breaking Syndicate news story on Soligenix »

Soligenix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HF

HFF Inc.

$35.34

0.08 (0.23%)

16:21
05/25/18
05/25
16:21
05/25/18
16:21
Hot Stocks
HFF Inc. announces $640M sale of 5 Bryant Park office tower in Manhattan »

HFF announces the $640M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/25/18
05/25
16:20
05/25/18
16:20
Options
Closing CBOE SPX and VIX Index summary for May 25th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.